Both in Pharmaceuticals
Relmada Therapeutics vs Prothena
Over the past year RLMD returned +50.5% and PRTA returned −18.2%; their daily moves had a correlation of 0.19.
RLMD +50.5% PRTA −18.2%Growth of $1, one year, split-adjusted
| Metric | RLMD | PRTA |
|---|---|---|
| Price | $4.17 | $8.39 |
| Market cap | $444.8M | $430.7M |
| Today | −2.34% | +2.19% |
| 1 month | +27.1% | +4.6% |
| 6 months | −46.9% | −25.0% |
| Year to date | −13.7% | −12.1% |
| 1 year | +89.5% | −20.4% |
| Revenue growth (YoY) | — | −77.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −1839.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.9× |
| Net cash | $217.7M | $288.2M |
| Dividend yield | — | — |
| Volatility (60d) | 60.0% | 45.9% |
| Short % of float | 14.0% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).